1 in 120 People Will Have a Million-Dollar Claim. Your Health Plan Was Never Built for That.

I work in this industry, so I'm going to tell you what most brokers won't say out loud. Your health plan is a living liability that most never see until it's too late, and the math behind it has gotten significantly worse over the last decade.

One in 120 people in the U.S. will generate a claim exceeding $1,000,000 at some point during their working years, based on current medical service costs. That's not a tail-risk footnote. That's a near-certainty at scale.

Why has the frequency of million-dollar claims increased so dramatically?

Million-dollar claimant frequency has grown more than 85% since 2014. That's not inflation alone. It's a combination of factors: specialty drug costs, advanced oncology treatments, cell and gene therapies, and the simple reality that medicine can now keep people alive through conditions that were previously fatal, at extraordinary cost.

Cancer sits at the center of this. It's both the most common and most expensive cause of high-dollar claims, claims exceeding $100,000 in a twelve-month period. Oncology drug costs alone have reshaped stop-loss pricing, and reinsurance pricing is up 15% in 2026 largely because of this trend. Your plan is absorbing that cost whether you see it itemized or not.

Meanwhile, the specialty drug pipeline through 2027 adds more high-cost claimants every cycle. This isn't slowing down.

How was health insurance originally designed, and how did it change?

Health insurance started as a catastrophic protection product. That was the original intent: you get hit by something devastating, the policy covers it. Routine care was your problem.

In the 1940s and 1950s, that model shifted. Employers competing for workers during labor shortages, with unions actively recruiting employees, started wrapping richer benefits around their job offers. First-dollar coverage for office visits and prescriptions became a competitive tool. It worked. And it stuck.

The problem is that it fundamentally distorted what health insurance is supposed to do. Covering a $30 office visit through an insurance mechanism that costs $6 to process makes no economic sense. But that's what the market normalized, and now employees expect it.

Where does your premium dollar actually go in a fully insured plan?

Federal law sets a floor. In the large group market, a carrier has to spend at least 85% of premium on claims and quality improvement. In the small group market, it's 80%. Taxes and regulatory fees come off the top before that math starts.

Everything else comes out of what's left: administration, broker commissions, sales and profit. Catastrophic claims aren't a separate bucket. A $1.2 million oncology claim and a $150 office visit are paid from the same claims dollars.

Here's the catch. The 85% is measured across the carrier's whole market in your state, averaged over three years. It isn't measured on your group. Run a 65% loss ratio and the carrier keeps 35 cents of every dollar you paid. No rebate is owed.

That's the price of a fixed premium. Some employers find the trade worth it. Many don't realize they're making it.

Self-funding doesn't make fixed costs disappear. It breaks them out. You pay a TPA, a stop-loss carrier (with its own overhead and profit), a PBM, network access and broker fees. Add them all up before you compare them to the carrier's 15%.

The real difference isn't the admin fee. It's what happens in a good year. Self-funded, the claims you didn't spend stay in your account, and you can see every one. Fully insured, a light year becomes carrier margin.

What does this mean for how you structure catastrophic protection?

If you're self-funded, your stop-loss attachment point is the most consequential number in your plan design. It determines how much catastrophic risk you're retaining versus transferring. With 1-in-120 odds on seven-figure claims, that number deserves real analysis, not a gut call.

Picking the right stop-loss attachment point isn't just about premium savings. It's about matching your cash reserves to the actual exposure your workforce carries. If you're self-funded and your broker isn't running that math with your specific census data, they're guessing.

Still fully insured? Your share of the carrier's large-claim risk is already baked into your premium. You're paying for it, but you can't see the claims, can't manage the utilization, and can't negotiate directly with providers on large cases.

One more thing most people don't know about large claims

Providers will negotiate payment plans. Whether you have insurance or not.

That fact alone won't solve a $1.2 million oncology claim. But it matters in the conversation about how plan design, reference-based pricing, and direct contracting interact with catastrophic exposure. The hospital's sticker price isn't the final number.

Most employers and most employees never learn that until after the damage is done.

The Census Bureau's 2026 small business reporting notes that Medicaid coverage declined in 2025 for the second consecutive year. As public coverage contracts, more of this catastrophic risk lands directly on employer-sponsored plans. The population you're insuring is shifting, even if your workforce isn't.

Understanding your actual claims exposure starts with data. Self-funding doesn't save you money. The data it unlocks does. That's still the most important sentence in this conversation.

Frequently asked questions

How does a company with 150 employees think about 1-in-120 million-dollar claim odds?

At 150 covered lives, you're statistically carrying more than one person who will generate a seven-figure claim during their working career. That doesn't mean it happens this year. But it means your stop-loss structure, your attachment point, and your reserve strategy all need to account for real probability, not best-case assumptions. A catastrophic claim on a 150-life self-funded plan without adequate stop-loss can threaten plan solvency. Use the Benefits Blueprint to stress-test your current structure against that scenario.

Is cancer really the top driver of high-dollar claims?

Yes. Cancer is both the most frequent and most costly cause of claims exceeding $100,000 in a twelve-month period. Specialty oncology drugs, immunotherapy, and surgical interventions stack quickly. A single cancer patient in active treatment can generate $400,000 to $800,000 in claims in one plan year, sometimes more. Stop-loss carriers price this into their models. You should too.

Do self-funded plans really cost less to run than fully insured plans?

Not always, and admin fees are the wrong comparison. A fully insured carrier's share is capped at 15% of premium in large group and 20% in small group, after taxes and fees. A self-funded plan pays a TPA, buys stop-loss with its own carrier margin, and pays PBM, network and broker fees separately. Add every fixed cost before you compare. The real differences are who keeps unspent claims dollars and who sees the data. Self-funded, both are yours. See the funding models overview for a side-by-side breakdown.

Can employers actually negotiate large medical claims directly with providers?

Yes. Hospitals and health systems negotiate payment arrangements on large balances routinely, with or without insurance. For self-funded employers using reference-based pricing or direct contracting strategies, this negotiation is a core part of the model. Even in fully insured plans, case managers sometimes facilitate these conversations. The key is knowing the option exists before the claim finalizes, not after.

What's the fastest way to understand my plan's catastrophic exposure?

Start with your claims data. If you're self-funded, your TPA can pull a claimant-level report showing your top 10 claimants by cost, their diagnoses, and their trajectory. If you're fully insured, you probably can't access that. That gap in visibility is one of the primary reasons employers move to self-funding. The Benefits Control System walks through how to read and act on that data once you have it.